J&J Seeking FDA Booster Approval

The FDA is expected to sign off on Moderna’s half-dose booster next week, and Pfizer is already offering its dose to high-risk people. Additionally, the New York Times reported Johnson & Johnson will join the club in asking regulators this week for the go-ahead to offer a second shot. NBC 6’s Carlos Suarez reports